Vyzula R - Search Results

1

Cardiac toxicity of targeted therapies used in the treatment for solid tumours: a review.

Svoboda M, Poprach A, Dobes S, Kiss I, Vyzula R. Svoboda M, et al. Among authors: vyzula r. Cardiovasc Toxicol. 2012 Sep;12(3):191-207. doi: 10.1007/s12012-012-9164-0. Cardiovasc Toxicol. 2012. PMID: 22528816 Review.

2

[In vitro testing for drug resistance and drug sensitivity in clinical oncology].

Kiss I, Zaloudík J, Vyzula R, Tomásek J, Maláska J, Coufal O, Kocáková I. Kiss I, et al. Among authors: vyzula r. Vnitr Lek. 2001 Sep;47(9):621-6. Vnitr Lek. 2001. PMID: 11715667 Czech.

3

Raltitrexed plus oxaliplatin in the second-line treatment of metastatic colorectal cancer.

Vyzula R, Kocáková I, Demlová R, Kiss I, Dusek L, Jarkovský J. Vyzula R, et al. Neoplasma. 2006;53(2):119-27. Neoplasma. 2006. PMID: 16575467 Clinical Trial.

4

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer.

Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R. Slaby O, et al. Among authors: vyzula r. Oncology. 2007;72(5-6):397-402. doi: 10.1159/000113489. Epub 2008 Jan 15. Oncology. 2007. PMID: 18196926 Clinical Trial.

5

[Involvement of microRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology].

Slabý O, Krekác D, Hrstka R, Svoboda M, Vyzula R. Slabý O, et al. Among authors: vyzula r. Cas Lek Cesk. 2008;147(1):25-31. Cas Lek Cesk. 2008. PMID: 18323039 Review. Czech.

6

[Gene expression profiling in prediction of tumor response to neoadjuvant concomitant chemoradiotherapy in patients with locally advanced rectal carcinoma: pilot study].

Garajová I, Slabý O, Svoboda M, Fabian P, Silák J, Smerdová T, Kocák I, Růzicková J, Hoch J, Vyzula R. Garajová I, et al. Among authors: vyzula r. Cas Lek Cesk. 2008;147(7):381-6. Cas Lek Cesk. 2008. PMID: 18678097 Slovak.

7

[Treatment of seminoma I stage disease].

Vyskocil J, Poprach A, Petrákova K, Lakomý R, Vyzula R, Coupek P. Vyskocil J, et al. Among authors: vyzula r. Klin Onkol. 2008;21(3):86-92. Klin Onkol. 2008. PMID: 19097416 Review. Czech.

8

[Chemosensitivity prediction in tumor cells ex vivo--difficulties and limitations of the method].

Michalová E, Poprach A, Nemecková I, Nenutil R, Valík D, Zaloudík J, Vyzula R, Vojtesek B. Michalová E, et al. Among authors: vyzula r. Klin Onkol. 2008;21(3):93-7. Klin Onkol. 2008. PMID: 19097417 Review. Czech.

9

[Actual state of ex vivo chemoresistance testing of malignant tumors in Masaryk Memorial Cancer Institute Brno].

Poprach A, Michalová E, Pavlík T, Lakomy R, Vyskocil J, Nemeccek R, Zaloudík J, Vyzula R, Kocák I, Kocáková I. Poprach A, et al. Among authors: vyzula r. Klin Onkol. 2008;21(3):116-21. Klin Onkol. 2008. PMID: 19097421 Czech.

10

[Cardiotoxicity of drugs used in oncology].

Poprach A, Petráková K, Vyskocil J, Lakomý R, Nemecek R, Kocák I, Kocáková I, Vyzula R. Poprach A, et al. Among authors: vyzula r. Klin Onkol. 2008;21(5):288-93. Klin Onkol. 2008. PMID: 19202960 Review. Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters